BOC Sciences is a supplier of specialty chemicals specializing in nucleotides, ribonucleotides and phosphoramidites. On April 6-7, 2022, BOC Sciences will participate in the 8th international Oxford conference on antisense and therapeutic nucleic acids as a sponsor, held at St Hilda's College, Oxford.
Nucleic acid therapy (NAT), including genome editing, ASO, siRNA, mRNA and gene therapy, can precisely modulate and potentially correct gene expression in diseases. 2020 and 2021 are years of rapid development of nucleic acid therapeutic applications, and novel therapeutic solutions were innovated for disease targets that were previously thought to be beyond the reach of traditional small molecules and biologics. A revolution in NAT therapies is on the way.
The 8th international Oxford conference on antisense and therapeutic nucleic acids provided a platform for attendees to communicate with experts, study the development of synthetic oligonucleotides as therapeutic drugs, and review scientific seminars presented by experts in the field.
Oligo 2022 Oxford: Antisense & Therapeutic Nucleic Acids, organized by LibPubMedia, will be held at St Hilda's College, Oxford, on April 6-7, 2022!
The conference brings together chemists and biologists from institutions to industries and aims to enhance participants' understanding of biological processes underlying oligonucleotides synthesis as therapeutic drugs, including molecular and cellular biology, pharmacology, rational optimization strategies, targeting and process development solutions. Nevertheless, this conference will allow participants to investigate the most updated industrial development trends of nucleic acid therapeutic, have in-depth discussions related to industrial development opportunities and pain points, and accelerate the research and development of synthetic oligonucleotides as therapeutic drugs. The main topics to be addressed are:
BOC Sciences is a professional chemical supplier headquartered in New York, USA. Our sub-brand, BOC RNA, focuses on RNA technology and development in disease treatment. We offer a comprehensive range of RNA-related products and services, including siRNA design, synthesis, analysis, ligation, delivery and mRNA vaccines, covering all aspects of RNA drug development.
BOC RNA's featured services include but are not limited to:
We are ambitious, developing rapidly, and committed to providing high-quality products and services. We look forward to working with our future customers to explore more possibilities for gene therapeutics.